340B PATIENTS Act of 2025

The 340B PATIENTS Act of 2025 clarifies that drug manufacturers must offer discounted prices under the 340B program to covered entities - such as community health centers, hospitals, and clinics - regardless of how or where drugs are dispensed, including through contracted pharmacies. It prohibits manufacturers from imposing restrictions on covered entities, such as limiting delivery locations, requiring extra data, or restricting how discounted drugs are used. The bill also establishes civil penalties for violations, including daily fines of up to $2 million, and allows covered entities to file claims for breaches of these rules. This ensures that covered entities can continue using contract pharmacies to access specialty drugs for patients with chronic or serious conditions.